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Background: Recent studies have revealed that interactions between tumour cells and the surrounding stroma
play an important role in facilitating tumour growth and invasion. Stromal fibroblasts produce most of the
extracellular matrix components found in the stroma. The aim of this study was to investigate mechanisms involved
in tumour cell-mediated regulation of extracellular matrix and adhesion molecules in co-cultured fibroblasts. To this
end, microarray analysis was performed on CCD-1068SK human fibroblast cells after direct co-culture with MDA-MB-
231 human breast tumour cells.
Results: We found that the expression of both connective tissue growth factor (CTGF/CCN2) and type I collagen
was negatively regulated in CCD-1068SK fibroblast cells under direct co-culture conditions. Further analysis revealed
that Smad7, a known negative regulator of the Smad signalling pathway involved in CCN2 promoter regulation,
was increased in directly co-cultured fibroblasts. Inhibition of Smad7 expression in CCD-1068SK fibroblasts resulted
in increased CCN2 expression, while Smad7 overexpression had the opposite effect. Silencing CCN2 gene
expression in fibroblasts led, in turn, to a decrease in type I collagen mRNA and protein levels. ERK signalling was
also shown to be impaired in CCD-1068SK fibroblasts after direct co-culture with MDA-MB-231 tumour cells, with
Smad7 overexpression in fibroblasts leading to a similar decrease in ERK activity. These effects were not, however,
seen in fibroblasts that were indirectly co-cultured with tumour cells.
Conclusion: We therefore conclude that breast cancer cells require close contact with fibroblasts in order to
upregulate Smad7 which, in turn, leads to decreased ERK signalling resulting in diminished expression of the
stromal proteins CCN2 and type I collagen.
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In normal mammary tissue, epithelial cells form ducts
and glands that are separated from the surrounding con-
nective tissue by a basement membrane. The connective
tissue, or stroma, is made up of fibrillar extracellular
matrix (ECM), capillaries and cells such as fibroblasts,
immune and inflammatory cells [1,2] and serves as a
barrier that impedes tumour development [3-5].* Correspondence: iqbal.parker@icgeb.org
†Equal contributors
1International Centre for Genetic Engineering and Biotechnology (ICGEB),
Anzio Rd Observatory, Cape Town 7925, South Africa
2Division of Medical Biochemistry & the Institute of Infectious Diseases and
Molecular Medicine, Faculty of Health Sciences, University of Cape Town,
Cape Town, South Africa
Full list of author information is available at the end of the article
© 2013 van Rooyen et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumHowever, complex tumour-stromal interactions may result
in changes to the stroma that facilitate breakdown of the
basement membrane and allows tumour cells to invade
the surrounding ECM. Here, the tumour cells interact
with both ECM components and stromal cells in a way
that would not occur under normal conditions, and this
may facilitate further tumour invasion and metastasis
[3,5-10]. Stromal fibroblasts are responsible for synthesiz-
ing and depositing most of the ECM components and,
therefore, interactions between tumour cells and fibro-
blasts play an important role in determining how tumour
cells alter the ECM to facilitate tumour invasion.
Structural proteins such as collagen, fibronectin and lam-
inin make up a large proportion of the ECM. However, an-
other group of proteins known as matricellular proteins arentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Differential expression of genes in CCD-1068SK
fibroblasts after co-culture with MDA-MB-231 breast
tumour cells
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do not play a direct role in maintaining physical structure
but are rather involved in modulating and co-mediating cel-
lular responses through interactions with cell surface recep-
tors, growth factors, cytokines and matrix proteins [11,12].
Connective tissue growth factor (CTGF) or CCN2 is a
member of the CCN family of matricellular proteins and
mainly acts through interactions with cell adhesion recep-
tors such as integrins and heparin sulfate proteoglycans
(HSPGs) [12]. CCN2 expression is regulated mainly at the
transcriptional level [13,14] and one of the most potent in-
ducers of CCN2 gene expression in fibroblasts, but not in
epithelial cells, is transforming growth factor beta (TGFβ)
[14,15]. Regulation of CCN2 gene expression by TGFβ in-
volves the association of a Smad3/Smad4 complex with a
Smad binding element (SBE) on the CCN2 promoter [16].
The CCN2 promoter also has a TGFβ response element
(TGFβRE) which appears to be important for the regula-
tion of basal CCN2 gene expression in fibroblasts, and is
therefore also called the basal control element (BCE-1)
[16]. Other signalling pathways that are involved in basal
and TGFβ-mediated CCN2 up-regulation include the Ras/
MEK/ERK and protein kinase C (PKC) pathways [14,17].
CCN2 is thought to act mainly as a co-mediator of
TGF-β’s ability to promote type I collagen synthesis, as
ccn2−/− embryonic fibroblasts were unable to induce
type I collagen synthesis in response to TGFβ [18]. An
important relationship therefore exists between TGFβ,
CCN2 and type I collagen, and in aged human skin
(≥ 80 years) the expression of all three of these proteins
is co-ordinately reduced when compared to levels in
younger skin samples (21–30 years) [19].
Current knowledge of the role tumour cells play in regu-
lating the expression of various components of the ECM in
the tumour environment is limited. In this study we inves-
tigated this further by using microarray technology to
measure changes in the expression of ECM components
and adhesion molecules in human fibroblasts that were co-
cultured with human breast tumour cells. We show that
MDA-MB-231 breast tumour cells negatively regulate
CCN2 and type I collagen gene expression in CCD-
1068SK fibroblasts in a Smad7-dependent manner through
decreased activation of the MEK/ERK signalling pathway.
This effect was only observed in CCD-1068SK fibroblasts
that were directly co-cultured with MDA-MB-231 tumour
cells, suggesting that breast tumour cells require close con-
tact with fibroblasts in the tumour microenvironment to
influence the expression of ECM components.
Results
The effect of tumour cell/fibroblast co-culture on ECM
and adhesion molecule gene expression
To investigate the effect of close contact with tumour
cells on the expression of cell adhesion and ECMcomponents in fibroblasts, cells were directly co-
cultured and subsequently separated before further gene
expression analysis. CCD-1068SK human fibroblasts
pre-labelled with PKH-67 green fluorescent dye were
mixed with an equal number of MDA-MB-231 human
breast tumour cells, co-cultured for 48 hours and sepa-
rated from the tumour cells by FACS for subsequent
RNA isolation to profile the expression of several ECM
genes by means of the Oligo GEArray® Human Extracel-
lular Matrix and Adhesion Molecules microarray
(SABiosciences) (Additional file 1: Table S1). The array
analysis showed that direct co-culture with MDA-MB-
231 tumour cells led to an increase in the expression of
matrix metalloprotease 1 (MMP1) in CCD-1068SK fi-
broblasts relative to CCD-1068SK mono-cultures while
the expression of a number of collagen genes was
down-regulated (Table 1). Interestingly, the expression
of connective tissue growth factor (CTGF/CCN2) was
substantially decreased in co-cultured fibroblasts.
The microarray findings for MMP1, COL1A1,
COL1A2 and CCN2 were independently confirmed by
quantitative real-time RT-PCR, showing that MMP1
gene expression was significantly up-regulated while
COL1A1, COL1A2 and CCN2 mRNA levels were sig-
nificantly decreased in fibroblasts that were co-cultured
with tumour cells (Figure 1A). Both CCN2 and type I
collagen are known to be positively regulated in re-
sponse to TGFβ via the Smad signalling pathway [14,20]
and, since both CCN2 and type I collagen were nega-
tively regulated in fibroblasts in response to tumour cell
co-culture, we investigated the expression of the nega-
tive regulator of TGFβ signalling, Smad7. Indeed, Smad7
gene expression was significantly increased in co-cultured
compared to mono-cultured fibroblasts (Figure 1A).
These findings were further supported by Western Blot
analysis showing that Smad7 protein was elevated in co-





Figure 1 MDA-MB-231 tumour cells influence the regulation of MMP1, type I collagen and Smad7 gene expression in CCD-1068SK
fibroblasts during direct co-culture. For direct co-culture experiments, CCD-1068SK fibroblasts were labelled with green fluorescent dye, PKH67,
mixed with an equal number of MDA-MB-231 breast tumour cells and co-cultured for 48 hours in serum-free medium. Fibroblasts were separated
from tumour cells by FACS and used for further analysis. CCD-1068SK monocultures were used as controls. (A) Quantitative real-time RT-PCR
analysis of MMP1, COL1A1, COL1A2, CCN2 and Smad7 mRNA levels in co-cultured CCD-1068SK fibroblasts. The graph shows the mean ± SD from
a representative experiment, relative to GAPDH (*p ≤ 0.05, n = 3). (B) Western blotting results show endogenous α1(I) and α2(I) procollagen,
CCN2 and Smad7 protein levels in CCD-1068SK fibroblasts after direct co-cultures. β-tubulin was used as a loading control. (C) De novo synthesis
of type I collagen measured by [3H]-proline incorporation into CCD-1068SK/MDA-MB-231 direct co-culture medium. CCD-1068SK fibroblasts
monocultures and co-cultures with non-tumourigenic MCF12A cells were used as controls. The medium was run on an 8% SDS-PAGE gel and
exposed to film for 7 days at −80°C, before being developed. (D) Quantitative real-time RT-PCR of indirectly co-cultured cells as described show
relative COL1A1, COL1A2, CCN2 and Smad7 mRNA levels in CCD-1068SK fibroblasts. The graph shows the mean ± SD from a representative
experiment (n = 3). (E) Western blotting results show endogenous α1(I) and α2(I) procollagen levels, CCN2 and Smad7 in CCD-1068SK fibroblasts
after indirect co-culture with tumour cells. β-tubulin was used as a loading control. Abbreviations: CCD, CCD-1068SK; MDA, MDA-MB-231. Brackets
enclose the cell line with which CCD-1068SK fibroblasts were co-cultured.
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tion of radioactively labeled α1(I) and α2(I) procollagen
chains synthesized by CCD-1068SK fibroblasts duringco-culture with MDA-MB-231 cells was investigated
by adding [3H]-proline to the culture medium during
the period of co-culture. We found lower levels of
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from CCD-1068SK/MDA-MB-231 co-cultures compared
to levels in CCD-1068SK monocultures or CCD-1068SK
co-cultured with MCF12A breast epithelial cells that
served as a benign control (Figure 1C). These results
suggest that, when in direct contact with fibroblasts,
MDA-MB-231 tumour cells were able to negatively regu-
late the expression of certain ECM components in CCD-
1068SK fibroblasts, including CCN2 and type I collagen.
This regulation may occur through up-regulation of the
negative regulator, Smad7.
Tumour cells may be communicating with fibroblasts
in a paracrine manner by secreting soluble factors such
as cytokines and growth factors that can modulate
Smad7, CCN2 and type I collagen gene expression in
neighbouring fibroblasts via such secreted factors. To in-
vestigate this possibility, an indirect co-culture system
was used in which CCD-1068SK fibroblasts were sepa-
rated from the MDA-MB-231 tumour cells using a
transwell insert with a 0.2 μm pore size. This allowed se-
creted factors to pass through but prevented direct con-
tact between fibroblasts and tumour cells. Analysis of
gene expression by quantitative real-time RT-PCR in
indirectly co-cultured CCD-1068SK fibroblasts revealed
that tumour cells did not influence the expression of
COL1A1, COL1A2, CCN2 or Smad7 when compared to
fibroblast monocultures (Figure 1D). In fact, Western
Blot analysis revealed that CCN2 protein levels were in-
creased while Smad7 was decreased (Figure 1E). These
results suggest that tumour cell-mediated regulation of
Smad7, CCN2 and type I collagen expression in fibro-
blasts was dependent on the contacts with or close prox-
imity of the tumour cells to these fibroblasts.
Smad7 influences the expression of CCN2 and type I
collagen gene expression
To determine whether the observed increase in Smad7 was
associated with decreased CCN2 and type I collagen levels,
Smad7 gene expression in CCD-1068SK fibroblasts was al-
tered by both gene silencing as well as transient
overexpression. siRNA mediated knock-down of Smad7 in
fibroblasts resulted in a substantial increase in both CCN2
mRNA and protein levels compared to controls (Figure 2A
and B). Although all Western Blots were performed under
denaturing conditions, we observed the appearance of both
monomeric and dimeric forms of CCN2 protein at 36 kDa
and 72 kDa, respectively, with a specific increase in CCN2
dimerization in Smad7 knock-down fibroblasts (Figure 2B).
The levels of α1(I) and α2(I) procollagen were also in-
creased in Smad7 knock-down fibroblasts compared to
control fibroblasts, although only COL1A1 levels appeared
to be affected at an mRNA level (Figure 2A and B).
Transfecting CCD-1068SK fibroblasts with the Smad7
overexpression plasmid pORF9-hSmad7 caused a significantdecrease in CCN2, COL1A1 and COL1A2 mRNA levels
(Figure 2C), which is in agreement with the expression
data shown in Figure 1A. While Smad7 protein levels
were found to peak 8 hours post transfection, the effect
on CCN2 and type I collagen gene expression was only
observed after 48 hours (Figure 2D). These results
suggest that increased levels of Smad7 in CCD-1068SK
fibroblasts can negatively affect the expression of both
CCN2 and type I collagen, as observed in fibroblasts
after direct co-culture with MDA-MB-231 tumour cells
(Figure 1A and B).
CCN2 is a positive regulator of type I collagen gene
expression
Previous studies have suggested that changes in CCN2
expression can affect type I collagen gene expression in
fibroblasts [19,21]. We therefore investigated whether
CCN2 knock-down in CCD-1068SK fibroblasts would
have a downstream effect on type I collagen gene ex-
pression. CCD-1068SK fibroblasts were transfected with
increasing concentrations of CCN2 siRNA and incu-
bated for an additional 48 hours. Western blot analysis
of the extracted protein showed that silencing CCN2
had a negative regulatory effect on both α1(I) and α2(I)
procollagen gene expression (Figure 3A). CCD-1068SK
fibroblasts transfected with 40 nM CCN2 siRNA were
also subjected to quantitative real-time RT-PCR analysis,
and showed an associated decrease in both COL1A1 and
COL1A2 mRNA levels observed as a result of CCN2
knock-down (Figure 3B). Inhibition of CCN2 gene ex-
pression in CCD-1068SK fibroblasts therefore associates
with decreased type I collagen expression in these cells.
A role for ERK1/2 in the regulation of CCN2 and type I
collagen gene expression
Previous studies have shown that the MEK/ERK signal-
ling pathway is a positive regulator of CCN2 gene ex-
pression [14,17,22]. We therefore investigated whether
changes in MEK/ERK signalling could account for the
observed decreased CCN2 gene expression in CCD-
1068SK fibroblasts co-cultured with MDA-MB-231
tumour cells. We found that direct, but not indirect, co-
culture of fibroblasts with tumour cells led to a substan-
tial decrease in phosphorylated ERK 1 and ERK 2 when
compared to fibroblast monocultures (Figure 4A) while
the levels of total ERK remained unchanged in both dir-
ect and indirect co-cultures. Since fibroblasts directly
co-cultured with tumour cells were found to have ele-
vated Smad7 gene expression with downstream effects
on CCN2 and type I collagen (Figures 1 and 2), we
therefore asked whether Smad7 affects activation of the
ERK signalling pathway. We transiently transfected
CCD-1068SK fibroblasts with pORF-hSmad7 and found
that overexpression of Smad7 (as shown in Figure 2C)
BA
DC
Figure 2 Differential Smad7 expression leads to changes in the expression of CCN2 and type I collagen in CCD-1068SK fibroblasts.
CCD-1068SK fibroblasts were transfected with 80 μM Smad7 siRNA and incubated for 48 hours before isolating RNA and protein for further
analysis. Fibroblasts transfected with scrambled siRNA were used as a control. (A) Quantitative real-time RT-PCR results show levels of Smad7, CCN2,
COL1A1 and COL1A2 mRNA relative to GAPDH (*p≤ 0.05, ** p≤ 0.01, n = 3). (B) Western blotting results show Smad7, α1(I) and α2(I) procollagen and
CCN2 levels in Smad7 knock-down fibroblasts compared to control fibroblasts. The CCN2 antibody detected a band at 36-38 kDa and 72 kDa that
represent monomeric and dimeric forms of the protein. (B) For Smad7 overexpression experiments, CCD-1068SK fibroblasts were transiently
transfected with 1 μg of the pORF9-hSmad7 plasmid. RNA and protein was isolated 8 hours and 48 hours after transfection. (C) Relative levels of
Smad7, CCN2, COL1A1 and COL1A2 were quantified by means of quantitative real-time RT-PCR analysis (*p≤ 0.05, ** p≤ 0.01, n = 3). (D) Antibodies
against Smad7, CCN2 and type I collagen were used to detect the respective protein levels by means of Western blot analysis. β-tubulin was used as a
loading control.
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low levels of phosphorylated ERK1/2 observed 48 hours
post transfection (Figure 4B).
To determine whether decreased activation of the
MEK/ERK signalling pathway could be associated with
decreased expression of CCN2 and type I collagen,
CCD-1068SK fibroblasts were cultured in the presenceof the MEK pathway inhibitor U0126. Western blot re-
sults showed that decreased ERK 1/2 phosphorylation
resulted in a decrease in CCN2 protein and mRNA
levels in CCD-1068SK fibroblasts (Figure 3C and D)
while no significant effect was observed on COL1A1 and
COL1A2 gene expression. These results suggest that the
increase in Smad7 levels observed in directly co-cultured
BA
Figure 3 CCN2 knock-down leads to decreased expression of type I collagen. CCD-1068SK fibroblasts were transfected with 20 to 80 μM of
CCN2 siRNA and incubated for 48 hours before isolating RNA and protein for further analysis. Fibroblasts transfected with scrambled siRNA were
used as a control. (A) CCN2 and type I procollagen protein levels in CCN2 knock-down fibroblasts, analysed by Western blotting. β-tubulin was
used as a loading control. (B) Real-time PCR results show relative COL1A1, COL1A2 and CCN2 mRNA levels, relative to GAPDH (*p ≤ 0.05,
** p ≤ 0.01, n = 3).
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which has downstream effects mainly on CCN2
expression.
Discussion
It has recently been shown that genetic mutations are not
the only factors that play a role in the progression of
transformed epithelial cells to invasive tumour cells, but
that continuous communication with the surrounding
stroma may also facilitate tumour development [8,23,24].
If tumours progress to the invasive stage, the basement
membrane which usually separates the tumour cells from
the fibroblasts is degraded, allowing tumour cells to
invade into the surrounding stroma where they come
into close contact with stromal fibroblasts. Since these
fibroblasts are the main producers of the components
making up the ECM, close interactions with tumour
cells could influence ECM production by these fibro-
blasts with further consequences for tumour migration
and invasion.
In the present study we established an in vitro co-
culture model of MDA-MB-231 breast tumour cells and
normal CCD-1068SK breast skin fibroblasts and applied
microarray analysis to identify the genes affected by dir-
ect cell-cell contact during culture. We showed that
tumour cells are able to down-regulate the expression of
ECM genes such as type I collagen and CCN2, while up-
regulating the expression of collagenases such as MMP1
in neighbouring fibroblasts. Moreover, we identified
Smad7 as a putative negative regulator of both CCN2
and type I collagen gene expression in fibroblasts, with
Smad7 mRNA and protein levels being significantly in-
creased in CCD-1068SK fibroblasts that were directly
co-cultured with MDA-MB-231 tumour cells. Import-
antly, these effects were found to be a result of direct
cell-cell contact and not mediated by growth factors or
cytokines secreted into the medium, as shown by indir-
ect co-culture experiments.Previous studies have shown that overexpression of
Smad7 reduces TGFβ-stimulated CCN2 gene expression,
but has no effect on the basal expression of CCN2 [16].
However, ELISA analysis performed in our laboratory
showed that CCD-1068SK fibroblasts secrete TGFβ in
monocultures (results not shown), and it is therefore
possible that Smad7 plays a role in negatively regulating
autocrine TGFβ in these fibroblasts. Moreover, CCN2
has been shown to act as a co-mediator of TGFβ’s ability
to promote type I collagen synthesis [18,25], suggesting
that the decreased type I collagen gene expression ob-
served in CCD-1068SK fibroblasts co-cultured with
MDA-MB-231 tumour cells could occur as a result of
the negative regulatory effect of increased Smad7 ex-
pression on CCN2 gene expression. Indeed, the siRNA
experiments in CCD-1068SK fibroblasts showed that
knockdown of CCN2 led to decreased levels of type I
collagen, also confirming previous studies showing that
changes in CCN2 expression can affect type I collagen gene
expression in fibroblasts [19,21]. Smad7 overexpression
has previously been shown to decrease COL1A1 mRNA
levels in normal human fibroblasts [26], which supports
our results obtained in fibroblasts directly co-cultured
with tumour cells.
Transcription of Smad7 is known to be positively reg-
ulated by TGFβ signalling, leading to downstream inhib-
ition of TGFβ/Smad signalling by Smad7 as part of a
negative feedback loop [27-29]. Overexpression of
Smad7 in tumour-associated fibroblasts may therefore
result in their unresponsiveness to TGFβ signalling. In-
deed, recent evidence suggests that fibroblasts unable to
respond to TGFβ facilitate tumour growth [30]. By
transplanting fibroblasts lacking the TGFβ receptor into
mice together with mammary carcinoma cells, the ag-
gressiveness and metastatic ability of the resulting tu-
mours was shown to increase when compared to that
observed in tumour cells transplanted together with nor-
mal fibroblasts. The altered fibroblasts produced TGFα
Figure 4 Smad7-dependent decreased activation of ERK1/2 in CCD-1068SK fibroblasts directly co-cultured with MDA-MB-231. (A) CCD-
1068SK fibroblasts were directly or indirectly co-cultured with an equal number of MDA-MB-231 tumour cells and incubated for 48 hours. Levels
of p-ERK 1/2 (T402, Y404) were measured in co-cultured CCD-1068SK fibroblasts by means of Western blot analysis and compared to levels in
CCD-1068SK monocultures. ERK1/2 and β-tubulin levels were detected as experimental controls. (B) CCD-1068SK fibroblasts transfected with the
pORF9-hSmad7 and overexpressing Smad7, as shown in Figure 2D, were used for further analysis of p-ERK 1/2 levels. ERK1/2 and β-tubulin served
as controls. (C) The MEK/ERK inhibitor U0126 was added to CCD-1068SK fibroblasts and incubated for 48 hours. Protein was isolated for Western
blot analysis of p-ERK 1/2 as well as CCN, Smad7 and type I procollagen. ERK1/2 and β-tubulin were used as controls. (D) Quantitative real-time
RT-PCR was used to measure COL1A1, COL1A2 and CCN2 mRNA levels in CCD-1068SK fibroblasts incubated with U0126 inhibitor for 48 hours
(*p≤ 0.05, ** p≤ 0.01, n = 3).
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accelerated tumour cell growth. Since TGFβ also usually
suppresses destructive immune and inflammatory re-
sponses [31,32], preventing the action of this tumoursuppressor in breast cancer could result in tumour-
promoting inflammatory conditions [23,33].
The upstream events leading to Smad7 overexpression
in the herein described direct co-culture model of CCD-
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yet been determined. Our results suggest that regulation oc-
curs at the transcriptional level as Smad7 mRNA levels were
found to be significantly increased. Previous studies investi-
gating Smad7 regulation have mainly focussed on the effect
of various cytokines on Smad7 expression. Those found to
increase Smad7 levels include IFNγ via JAK/Stat signalling
[34] and IL1β via either JNK or NFκB activation [35]. How-
ever, since Smad7 overexpression only occurred in fibro-
blasts directly co-cultured with tumour cells, this suggests
that cell surface factors may be involved in regulation of
Smad7. Further investigations would need to be per-
formed to determine these factors.
Investigating the intracellular signalling events leading to
CCN2 and type I collagen down-regulation, we found that
tumour cell-mediated up-regulation of Smad7 negatively af-
fected the MEK/ERK pathway. However, inhibition of this
pathway had more dramatic effects on CCN2 expression
while type I collagen was only slightly decreased. Previous
studies have suggested that Ras/MEK/ERK signalling posi-
tively regulates CCN2 promoter activity and is required for
basal CCN2 promoter activity [14,17,36,37]. However, the
effect of MEK/ERK signalling on type I collagen gene ex-
pression is not clear. Some studies suggest that MEK/ERK
activation negatively regulates type I collagen expression
[38]. However, addition of IL-4 or IL-13 to dermal fibro-
blasts also increases type I collagen promoter activity in an
ERK-dependent manner [39]. The effect of MEK/ERK sig-
nalling on type I collagen gene expression therefore appears
to be dependent on interactions with other signalling path-
ways and on the cell context. Recent studies have shown
that TGFβ-mediated up-regulation of both CCN2 and type
I collagen in fibroblasts requires activation of Alk1
(TGFBRI)/Smad1 and downstream ERK1/2 signalling [40]
and that the association of CCN2 with β3 integrin is re-
quired for TGFβ-mediated Smad1 phosphorylation [25]. Si-
lencing Smad1 gene expression resulted in a decrease in the
expression of both TGFβ-stimulated CCN2 and type I colla-
gen gene expression as well as basal type I collagen gene ex-
pression [40]. CCN2 has, in turn, been shown to activate
ERK1/2 signalling by adhesion to the alpha1/beta6 integrin
receptor or syndecan 4, a heparin sulphate proteoglycan
[18,41]. The MEK/ERK signalling pathway therefore appears
to play an important role in positively regulating CCN2 ex-
pression which, in turn, leads to further increased activation
of MEK/ERK in a positive feedback loop. Deregulation of
the MEK/ERK signalling pathway in fibroblasts close to or
adjacent to tumour cells could therefore have important im-
plications for ECM synthesis and homeostasis.
Previous studies have shown that levels of type I colla-
gen gene expression were only decreased in later stages
of breast tumour progression [42] and in melanoma tis-
sue [43]. The negative regulation of tumour cells on
CCN2 and type I collagen gene expression in fibroblastsmay therefore be more likely to occur during the invasive
stages of breast cancer, when tumour cells are in close con-
tact with surrounding fibroblasts as a result of basement
membrane degradation. Close association with invasive
tumour cells could therefore cause the balance of ECM
synthesis/degradation to be disturbed by decreasing the
production of type I collagen and CCN2 in neighbouring fi-
broblasts and concurrently causing an increase in the ex-
pression of MMP1, a metalloproteinase that degrades type
I collagen. Previous studies performed on highly invasive
melanomas have shown that destabilization and degrad-
ation of the type I collagen matrix allows melanoma cells to
evade the growth arrest and apoptosis that these cells
would normally undergo in the presence of type I collagen
matrix [43]. Inhibiting MMP expression in MDA-MB-231
cells has also been shown to inhibit the migration of these
tumour cells through a bone marrow fibroblast monolayer
[44]. The results obtained in these studies suggest that the
decreased CCN2 and type I collagen matrix production
and increased MMP expression observed in our model sys-
tem of co-cultured CCD-1068SK fibroblasts could facilitate
MDA-MB-231 tumour cell invasion through the ECM.
However, further studies including primary human fibro-
blasts as well as breast tumour samples will need to be
undertaken to support the observations described here.
Conclusions
The co-culture model presented in this study revealed that
tumour cells influenced ECM gene expression by direct
cell-cell contact with fibroblasts. The observed effects were
found to be mediated by increased levels of Smad7 that
negatively influenced type I collagen and CCN2 expression,
the latter occurring in a MEK/ERK dependent manner
(Figure 5). To our knowledge, this is the first study showing
a negative regulatory effect of Smad7 on CCN2 and type I
collagen expression that is dependent on direct contact be-
tween fibroblasts and tumour cells. This type of close con-
tact between tumour cells and fibroblasts is only possible in
the later stages of breast cancer progression, when the base-
ment membrane separating these two cell types has been
degraded, and the resulting decrease in fibroblast-mediated
production of the surrounding extracellular matrix could
facilitate further tumour invasion and metastasis. Our re-
sults highlight the fact that invasive tumour cells may have
effects on closely associated fibroblasts that would not
occur under normal conditions and which could allow
tumour cells to escape the inhibitory effects of the matrix,
facilitating further tumour migration and invasion.
Methods
Cell culture
The cell lines CCD-1068SK (human breast fibroblasts),
MDA-MB-231 (human breast tumour cells) and MCF12A
(human non-tumorigenic epithelial cells) were purchased
Figure 5 Proposed model of breast tumour-mediated regulation of CCN2 and type I collagen in neighbouring fibroblasts in the
tumour microenvironment. While fibroblasts in the normal stroma maintain the structure and function of the ECM, direct contact of tumour-
associated fibroblasts with breast tumour cells in the tumour microenvironment leads to degradation of the ECM and/or fibrosis. We hypothesise
that this is caused by increased expression of Smad7 that downstream negatively affects the expression of CCN2 and type I collagen, partly
through inactivation of the MEK/ERK signalling pathway (illustration by I. Jastram).
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medium (DMEM, Invitrogen) supplemented with 10% (v/v)
heat-inactivated fetal calf serum (FCS, Invitrogen), 100 μg/
ml streptomycin and 100 U/ml penicillin (Invitrogen) in a
humidified atmosphere (5% CO2) at 37°C.
Direct co-culture
A total of 5×106 CCD-1068SK fibroblasts were labelled
with PKH67 green fluorescent dye (Sigma) in diluent C,
according to the manufacturer’s instructions. After ex-
tensive washing, the fibroblasts were mixed with an
equal number of MDA-MB-231 tumour cells, and
1.4×106 cells were seeded into 150 cm dishes. In parallel,
1.4×106 CCD-1068SK fibroblasts were seeded into separ-
ate 150 cm dishes and served as a control. Cells were
allowed to settle in complete medium for at least 12
hours before being washed twice with 1×PBS and incu-
bated in serum-free medium for a further 48 hours.
Indirect co-culture
CCD-1068SK at a density of 2×105 cells/well were seeded
into 6-well plates while an equal number of MDA-MB-231
or CCD-1068SK cells were seeded on transwell inserts
(NUNC, membrane pore size 0.2 μm) in separate 6-well
plates. Cells were allowed to settle in complete medium for
at least 12 hours before inserts were transferred into the 6-
well plates containing the fibroblasts. Medium was re-
moved, cells were washed twice with 1×PBS and incubated
in serum-free DMEM for a further 48 hours.
Fluorescence-activated cell sorting (FACS)
Directly as well as indirectly co-cultured cells were lifted
with 0.05% trypsin/5mM EDTA (pH 8), washed withcomplete medium and prepared for FACS in DMEM
containing 2% FCS. CCD-1068SK fibroblasts were sorted
based on green fluorescence using the BD FACS VANT-
AGE, collected in DMEM containing 2% FCS and used
for further RNA and protein analysis.
Oligo GEArray® human extracellular and adhesion
molecules microarray analysis
RNA was extracted from CCD-1068SK fibroblast using
the RNeasy® MinElute™ Cleanup Kit (Qiagen), according
to the manufacturer’s instructions. The TrueLabeling-
AMP™ 2.0 kit (SABiosciences) was used to synthesize
cDNA from 3 μg of each RNA sample. The amplified
cDNA then formed the template for further cRNA synthe-
sis, also using the TrueLabeling-AMP™ 2.0 kit. The cRNA
was purified using the ArrayGrade™ cRNA Cleanup Kit
(SABiosciences) and hybridized against Oligo GEArrays®
nylon membranes overnight at 60°C with continuous rota-
tion. Binding of biotinylated cRNA probes was detected
using alkaline phosphatase-conjugated streptavidin to-
gether with the Chemiluminescent Detection Kit
(SABiosciences). Array images were visualized using the
Syngene G:Box Chemi system. The images were uploaded
onto the web-based GEArray Expression Analysis Suite
for further analysis. The microarrays were done in dupli-
cate, background was normalized against two empty spots
on each array and gene expression was normalized against
ribosomal protein S27a (RPS27A) and β-actin (ACTB)
gene expression.
Quantitative real-time PCR
Total RNA was isolated from CCD-1068SK fibroblasts using
Qiazol reagent (Qiagen) according to the manufacturer’s
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http://www.biosignaling.com/content/11/1/75protocol and reverse transcribed using the ImProm-II™ Re-
verse Transcription System (Promega). cDNA generated
from 1 μg of total RNA was used for quantitative PCR with
the KAPA SYBR® FAST qPCR Kit (KAPA Biosystems) and
the relevant primer sets (Table 2) on a LightCycler® 480II
System (Roche). To determine relative gene expression, re-
sults were analysed using the 2-ΔΔCT method [45] and
normalised to GAPDH expression.
Western blot analysis
Cells were lysed in 1×RIPA buffer (Invitrogen)
containing 1×protease inhibitor (Roche) and 1×phos-
phatase inhibitor (Roche), and quantitated using the
BCA™ Protein assay kit (Pierce). Approximately 20 to 30
μg of protein was heat-denatured at 95°C, separated via
SDS-polyacrylamide gel electrophoresis and transferred
to a nitrocellulose membrane. Membranes were blocked
in 5% milk in TBS-Tween (TBST) for 1 hour and probed
with the following primary antibodies at 4°C overnight:
CTGF/CCN2 (L-20) (Santa Cruz Biotechnology), Smad7
(G-23) (Santa Cruz Biotechnology), type I collagen
(Southern Biotech), pERK1,2 (T202/Y204) (Cell Signal-
ling), Erk2 (Santa Cruz Biotechnology), and β-tubulin
(Santa Cruz Biotechnology). After washing with TBST,
membranes were incubated with the appropriate second-
ary antibody for 1 hour at room temperature. Protein
levels were visualized by chemiluminscence using the
LumiGlo® Reserve Substrate (KPL) and the VisionWorks
LS Biospectrum™ 500 Imaging System (UVP).
Transient transfections
CCD-1068SK fibroblasts were plated at a density of 2×105
cells per well in 6-well plates and allowed to settle over-
night to reach a final confluence of ca. 50%. For gene-
knockdown experiments, Transfectin lipid reagent (Bio-
Rad) was added in a 2:1 ratio to 20–80 μM CCN2 siRNA













R: CCTTAGCCGACTCTGCGAACTAserum-free DMEM and incubated at room temperature
for 20 min before being added drop-wise to the cells. Cells
were incubated overnight, medium was changed to
serum-free DMEM and cells were incubated for a further
24 hours before continuing with RNA and protein extrac-
tions as described above. CCD-1068SK fibroblasts
transfected with an equal amount of scrambled control
siRNA-A (Santa Cruz Biotechnology) were used as a nega-
tive control.
To transiently overexpress Smad7, 1 μg of the plasmid
pORF9-hSmad7 (InvivoGen) in 150 mM NaCl was
added to 2 μl JetPEI® reagent (Polyplus) in 150 mM NaCl
and incubated at room temperature for 20 min. A total
volume of 200 μl transfection mixture was then added
drop-wise to the cells. 8 h and 48 h post transfection,
RNA and protein were extracted from the cells and used
for further analysis as described above.
Analysing the incorporation of [3H]-proline into secreted
α1(I) and α2(I) procollagen
CCD-1068SK fibroblasts at a density of 2×105 cells were
mixed with an equal number of MCF12A or MDA-MB-
231 cells, seeded into 6-well plates and allowed to settle
overnight. Cells were then washed twice with 1×PBS,
after which 2 ml serum-free DMEM with 20 μCi/ml
[3H]-proline (American Radiolabeled Chemicals Inc), 50
mg/ml ascorbic acid and 50 mg/ml β-aminopropionitrile
was added to each well and incubated for 20 hours.
Medium was removed from cells, transferred to 2ml
microfuge tube and acetic acid was added to a final con-
centration of 0.5 M. Medium proteins were digested
with 100 μg/ml pepsin for 4 h at 20°C, with rotation.
Digested medium was transferred to dialysis tubing and
dialyzed overnight against 50 mM Tris, pH 7.5, with one
buffer change after 2 hours. Medium was transferred back
into microfuge tubes and precipitated with TCA overnight
at 4°C. The samples were centrifuged at 11 000 rpm forAnnealing temp. Product size Ref.
60°C 192 bp This study
60°C 83 bp [46]
60°C 78 bp [47]
60°C 650 bp This study
60°C 867 bp This study
60°C 137 bp [48]
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in 40 μl of SDS-Page loading buffer. An equal volume of
each sample was heat-denatured at 95°C for 5 minutes and
run on an 8% SDS-PAGE gel (with 4% stacking gel) for 80
minutes at 180 V. The gel was soaked in 1M sodium sali-
cylate for 1 hour, washed in distilled water for another hour
and placed on 3 mm Whatman paper, covered with saran
wrap and vacuum dried at 70°C for 2 hours. The dried gel
was placed in a cassette and exposed to film for 7 days at
−80°C, after which it was developed and fixed.
Statistical analysis
All experiments were performed in triplicate and re-
peated at least twice. Standard deviations (SD) were cal-
culated from triplicate samples by means of the two-
tailed Student’s t-test and a p-value ≤ 0.05 was regarded
as statistically significant.
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